Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes

Philips

Status: Completed

Conditions: Respiratory Failure; Severe Sepsis; Cardiac Arrest

Study type: Observational

Funder types: Industry

Identifiers

NCT01692847

12/WA/0050 (Other Identifier)

SD-05163-BBN-IGS

Details and patient eligibility

About

A hospitals manual method of patient monitoring will be implemented in an automated system and supported by an early patient deterioration detection for timely escalation. The purpose of this study is to assess if clinical outcomes of patients in Acute Care are significantly improved by such a system.

Full description

The purpose of this study is to assess if the Philips IntelliVue Guardian Solution (IGS) with all its components can significantly improve clinical outcomes for deteriorating patients on a general medical ward prior and after referral to the hospitals' Acute Care Team (ACT). Further, to provide evidence that the Philips IGS assists to increase the efficiency of a hospital's Early Warning Scoring process (afferent and efferent arm of the escalation system).

The introduction of such an intelligent automated system offers a unique opportunity to address the breakdown in the chain of prevention by strengthening the reliability of calls-for-help to responders through a technical solution with the potential for a more timely escalation where appropriate.

In this study the hospital's Standard of Care protocol for the monitoring of vital signs (including timing, vital signs collected and escalation instructions) will be implemented in a commercially available intelligent automatic monitoring and notification system. No investigational procedures or devices are associated with this protocol.

Enrollment: 678 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all patients admitted to the study units during the period of data collection

Exclusion criteria

• less than 24h on ward

Trial design

678 participants in 2 patient groups

RRT calls prior to IGS use

Description:

Patients who triggered ACT/RRT calls prior to the installation of the IGS (Intellivue Guardian System)

RRT calls during IGS use

Description:

Patients who triggered ACT/RRT calls after the installation of IGS. All patients on the study ward receive the same care in both groups. The only difference is the system used to collect vital signs and to inform the staff about patient deteriorations. In Group 2, the IGS (FDA approved and CE marked) is the vital signs collection and information system.